NEW YORK, Nov. 12 – The Federal Trade Commission has approved PerkinElmer's proposed acquisition of Packard BioScience and the deal is now set to close on November 13, PerkinElmer said Monday.

"We will now move quickly to integrate these highly complementary businesses into the world's premier provider of drug discovery solutions," Grergory Summe, CEO of PerkinElmer, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.